BRIEF published on 04/21/2026 at 07:35, 10 days 4 hours ago Sensorion is preparing for its Annual General Meeting Shareholders General Assembly Preparatory Documents Remote Voting Sensory
PRESS RELEASE published on 04/21/2026 at 07:30, 10 days 4 hours ago Terms of availability of the preparatory documents for the GM Sensorion provides Preliminary Documents for the Combined Shareholders' General Meeting of May 11, 2026. Shareholders urged to participate in a critical meeting addressing new therapies for hearing loss disorders Biotechnology Shareholders' Meeting Gene Therapy Sensorion Hearing Loss
BRIEF published on 03/23/2026 at 07:35, 1 month 9 days ago Sensorion continues its development in gene therapy for deafness Gene Therapy Congenital Deafness Audiogene Sense-501 Sense-601
BRIEF published on 03/23/2026 at 07:35, 1 month 9 days ago Sensorion Updates on Audiogene Trial and Advances GJB2-GT Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF published on 03/18/2026 at 07:35, 1 month 14 days ago Sensorion Reports 2025 Results and Corporate Updates Financial Results Gene Therapy Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 03/18/2026 at 07:30, 1 month 14 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2025 results, provides corporate update, and announces release of annual report. Key milestones in gene therapies for hearing loss. Financial highlights and future expectations highlighted Financial Highlights Full-year Results Sensorion Gene Therapies Future Milestones
BRIEF published on 02/17/2026 at 07:35, 2 months 12 days ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 2 months 12 days ago Sensorion announces changes in its management Change Of Direction Sensory Auditory Therapy Sanofi Financing Medical Pipeline
PRESS RELEASE published on 02/17/2026 at 07:30, 2 months 12 days ago Inside Information / Other news releases Sensorion announces Nawal Ouzren stepping down as CEO for personal reasons. Amit Munshi to serve as Interim CEO. Sanofi-led financing for pipeline assets Leadership Changes Sanofi Sensorion Amit Munshi Nawal Ouzren
BRIEF published on 02/06/2026 at 07:35, 2 months 23 days ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
Published on 05/01/2026 at 07:35, 4 hours 2 minutes ago Snipp Interactive Reports Financial Results for Q4 and Fiscal 2025; Announces Conference Call on May 5, 2026
Published on 05/01/2026 at 04:00, 7 hours 37 minutes ago Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 8 hours 12 minutes ago McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 8 hours 42 minutes ago GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 10 hours 37 minutes ago PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 11:27, 10 minutes ago AEQUITA completes acquisition of select European assets from LYB and launches Velogy
Published on 05/01/2026 at 10:15, 1 hour 22 minutes ago Custodian Property Income REIT plc: Total Voting Rights
Published on 04/30/2026 at 20:00, 15 hours 36 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 16 hours 21 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 16 hours 37 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 17 hours 27 minutes ago Minutes of the Combined General Meeting held on April 30, 2026
